All screening programmes do harm ; some also do good.
The responsibility of the policy-maker is to decide which programmes do more good than harm at reasonable cost and then introduce them, once they are confident that the screening programme could and will reach the standard of quality required for success.
The ratio of benefit to harm is not, however, constant and this relationship demonstrates a shifting balance.
Mots-clés Pascal : Dépistage, Programme sanitaire, Assurance qualité, Analyse avantage coût, Economie santé, Homme
Mots-clés Pascal anglais : Medical screening, Sanitary program, Quality assurance, Cost benefit analysis, Health economy, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0107679
Code Inist : 002B30A03A. Création : 16/11/1999.